Related Experiment Videos
Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease
Carlo Salvarani1, Luigi Boiardi, Bruno Casali
1Laboratorio di Biologia Molecolare, Ospedale di Reggio Emilia, Italy. salvarani.carlo@asmn.re.it
The Journal of Rheumatology
|March 23, 2002
Summary
The endothelial nitric oxide synthase (eNOS) Glu-Asp298 gene polymorphism is linked to Behçet's disease (BD) susceptibility. This specific eNOS variant was more common in BD patients, suggesting a genetic predisposition.
Area of Science:
- Genetics
- Immunology
- Molecular Biology
Background:
- Behçet's disease (BD) is a rare, multisystemic inflammatory disorder of unknown etiology.
- Genetic factors are implicated in BD pathogenesis, but specific gene associations require further investigation.
Purpose of the Study:
- To investigate the association between endothelial nitric oxide synthase (eNOS) gene polymorphisms and susceptibility to Behçet's disease.
- Specifically analyze the Glu-Asp298 polymorphism in exon 7 and the 4 a/b polymorphism in intron 4 of the eNOS gene.
Main Methods:
- Genotyping of 73 Italian BD patients and 135 healthy controls using polymerase chain reaction and allele-specific oligonucleotide techniques.
- Analysis focused on two specific polymorphisms within the eNOS gene: exon 7 (Glu-Asp298) and intron 4 (4 a/b).
Main Results:
- A significant difference in the distribution of the Glu-Asp298 genotype was observed between BD patients and controls (p(corr) = 0.00009).
- The Asp298 allele was found to be significantly more frequent in BD patients compared to controls (p(corr) = 0.0006, OR 2.1).
- No significant difference was found in the distribution of the eNOS 4 a/b genotype between the groups.
Conclusions:
- The Glu-Asp298 polymorphism in the eNOS gene is associated with an increased susceptibility to Behçet's disease.
- These findings suggest a potential role for eNOS genetic variations in the development of BD.